Biography and Research Information

OverviewAI-generated summary

Abdul H. Khan is a researcher with over 15 years of experience in preclinical drug development, integrative physiology, pharmacology, and in vivo preclinical and translational research. His work focuses on cardiovascular, renal, and anti-fibrotic drug development. Dr. Khan also has experience in clinical research, epidemiological research, health data collection, and data curation.

He has authored or co-authored 194 peer-reviewed publications, including recent work on kidney injury, vascular smooth muscle contractility, and the reproductive toxicity of microplastics. His scholarly impact is evidenced by a Google Scholar H-index of 31 and over 3,153 citations. Dr. Khan leads a research group and has collaborated with researchers at the University of Arkansas for Medical Sciences, including John D. Imig, Samaneh Goorani, Abhishek Mishra, and Henry A. Palfrey.

Dr. Khan has a strong commitment to academic mentorship, having guided undergraduate and medical students, postdoctoral fellows, and graduate students. His research contributions have been recognized with multiple awards, fellowships, and grants from organizations such as the American Heart Association.

Metrics

  • h-index: 31
  • Publications: 194
  • Citations: 3,153

Selected Publications

  • Renoprotective approaches against anthracycline nephrotoxicity (2026) DOI
  • EET-Based Therapeutics Mitigate Sorafenib-Associated Glomerular Cell Damage (2025) DOI
  • Dual acting inhibitor of soluble epoxide hydrolase and Cyclooxygenase-2, attenuates glomerular injury in renal hypoplasia mice (2025) DOI
  • Transforming growth factor β receptor 1 and mitogen-activated protein 4 kinase 4 dual inhibitor, TK-850, reduces renal fibrosis in unilateral ureteral–obstructed mice (2025) DOI
  • 591 Low kidney mass contributes to enhanced fractionated irradiation-induced renal hemodynamic dysfunction in mice (2025) DOI
  • Editorial: Debates in experimental pharmacology and drug discovery 2023: innovative approaches to chronic kidney disease drug discovery, identification of targets and safety assessment (2025) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics